Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces that new clinical ...
Daxor (NASDAQ:DXR) used its presentation at the iAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 to outline its focus on blood volume analysis and the company’s commercialization ...
Explore how Raman spectroscopy supports quantitative pharmaceutical analysis by enabling accurate measurement of active ...
The latest issue of Current Pharmaceutical Analysis (Volume 22, Issue 2, March 2026) is now available online, featuring new open access articles on pharmaceutical methodologies, drug analysis, and ...
CT Insider on MSN
Primal Herbs Volume orders recalled after FDA laboratory analysis finds undeclared ingredient
Primal Herbs Volume is being recalled after an undeclared ingredient used in Viagra was detected in the product.
BKREA releases the most comprehensive Manhattan investment sales study ever published — analyzing 29,363 transactions ...
Background Children represent fewer than 10% of emergency medical services (EMS) encounters in the USA. We evaluated whether ...
Workers and passengers on the Chicago Transit Authority have been assaulted at rates at least double those of comparable ...
SIREN posts 163% gain, but CMF turns negative. TRUMP OBV signals seller control heading to $2.71. MemeCore eyes $2.00.
Drivers love a good soundtrack. Windows down, volume up, and suddenly a regular commute feels like a movie scene. But ...
Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results